Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

NCT00426946 is registered in ClinicalTrials.gov with Geha Mental Health Center as lead sponsor.

NCT NCT00426946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00426946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study
Lead sponsor
Geha Mental Health Center
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2005
Completion date
Not reported
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression